Abstract
Background: Genome-wide association studies (GWAS) identified variants at 19p13.1 and ZNF365 (10q21.2) as risk factors for breast cancer among BRCA1 and BRCA2 mutation carriers, respectively. We explored associations with ovarian cancer and with breast cancer by tumor histopathology for these variants in mutation carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Methods: Genotyping data for 12,599 BRCA1 and 7,132 BRCA2 mutation carriers from 40 studies were combined. Results: We confirmed associations between rs8170 at 19p13.1 and breast cancer risk for BRCA1 mutation carriers [HR, 1.17; 95% confidence interval (CI), 1.07-1.27; P = 7.42 × 10 -4] and between rs16917302 at ZNF365 (HR, 0.84; 95% CI, 0.73-0.97; P = 0.017) but not rs311499 at 20q13.3 (HR, 1.11; 95% CI, 0.94-1.31; P = 0.22) and breast cancer risk for BRCA2 mutation carriers. Analyses based on tumor histopathology showed that 19p13 variants were predominantly associated with estrogen receptor (ER)-negative breast cancer for both BRCA1 and BRCA2 mutation carriers, whereas rs16917302 at ZNF365 was mainly associated with ER-positive breast cancer for both BRCA1 and BRCA2 mutation carriers.Wealso found for the first time that rs67397200 at 19p13.1 was associated with an increased risk of ovarian cancer for BRCA1 (HR, 1.16; 95% CI, 1.05-1.29; P = 3.8 × 10 -4) and BRCA2 mutation carriers (HR, 1.30; 95% CI, 1.10-1.52; P = 1.8 × 10-3). Conclusions: 19p13.1 and ZNF365 are susceptibility loci for ovarian cancer and ER subtypes of breast cancer among BRCA1 and BRCA2 mutation carriers. Impact: These findings can lead to an improved understanding of tumor development and may prove useful for breast and ovarian cancer risk prediction for BRCA1 and BRCA2 mutation carriers.
Original language | English |
---|---|
Pages (from-to) | 645-657 |
Number of pages | 13 |
Journal | Cancer Epidemiology Biomarkers and Prevention |
Volume | 21 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1 Jan 2012 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Cancer Epidemiology Biomarkers and Prevention, Vol. 21, No. 4, 01.01.2012, p. 645-657.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
AU - Couch, Fergus J.
AU - Gaudet, Mia M.
AU - Antoniou, Antonis C.
AU - Ramus, Susan J.
AU - Kuchenbaecker, Karoline B.
AU - Soucy, Penny
AU - Beesley, Jonathan
AU - Chen, Xiaoqing
AU - Wang, Xianshu
AU - Kirchhoff, Tomas
AU - McGuffog, Lesley
AU - Barrowdale, Daniel
AU - Lee, Andrew
AU - Healey, Sue
AU - Sinilnikova, Olga M.
AU - Andrulis, Irene L.
AU - Ozcelik, Hilmi
AU - Mulligan, Anna Marie
AU - Thomassen, Mads
AU - Gerdes, Anne Marie
AU - Jensen, Uffe Birk
AU - Skytte, Anne Bine
AU - Kruse, Torben A.
AU - Caligo, Maria A.
AU - Von Wachenfeldt, Anna
AU - Barbany-Bustinza, Gisela
AU - Loman, Niklas
AU - Soller, Maria
AU - Ehrencrona, Hans
AU - Karlsson, Per
AU - Nathanson, Katherine
AU - Rebbeck, Timothy R.
AU - Domchek, Susan M.
AU - Jakubowska, Ania
AU - Lubinski, Jan
AU - Jaworska, Katarzyna
AU - Durda, Katarzyna
AU - Zołwocka, Elzbieta
AU - Huzarski, Tomasz
AU - Byrski, Tomasz
AU - Gronwald, Jacek
AU - Cybulski, Cezary
AU - Goŕski, Bohdan
AU - Osorio, Ana
AU - Durań, Mercedes
AU - Tejada, María Isabel
AU - Benitez, Javier
AU - Hamann, Ute
AU - Hogervorst, Frans B.L.
AU - Van Os, Theo A.
AU - Van Leeuwen, Flora E.
AU - Meijers-Heijboer, Hanne E.J.
AU - Wijnen, Juul
AU - Blok, Marinus J.
AU - Kets, Marleen
AU - Hooning, Maartje J.
AU - Oldenburg, Rogier A.
AU - Ausems, Margreet G.E.M.
AU - Peock, Susan
AU - Frost, Debra
AU - Ellis, Steve D.
AU - Platte, Radka
AU - Fineberg, Elena
AU - Evans, D. Gareth
AU - Jacobs, Chris
AU - Eeles, Rosalind A.
AU - Adlard, Julian
AU - Davidson, Rosemarie
AU - Eccles, Diana M.
AU - Cole, Trevor
AU - Cook, Jackie
AU - Paterson, Joan
AU - Brewer, Carole
AU - Douglas, Fiona
AU - Hodgson, Shirley V.
AU - Morrison, Patrick J.
AU - Walker, Lisa
AU - Porteous, Mary E.
AU - Kennedy, M. John
AU - Side, Lucy E.
AU - Bove, Betsy
AU - Godwin, Andrew K.
AU - Stoppa-Lyonnet, Dominique
AU - Fassy-Colcombet, Marion
AU - Castera, Laurent
AU - Cornelis, Franco̧is
AU - Mazoyer, Sylvie
AU - Leóne, Meĺanie
AU - Boutry-Kryza, Nadia
AU - Bressac-de Paillerets, Brigitte
AU - Caron, Olivier
AU - Pujol, Pascal
AU - Coupier, Isabelle
AU - Delnatte, Capucine
AU - Akloul, Linda
AU - Lynch, Henry T.
AU - Snyder, Carrie L.
AU - Buys, Saundra S.
AU - Daly, Mary B.
AU - Terry, Mary Beth
AU - Chung, Wendy K.
AU - John, Esther M.
AU - Miron, Alexander
AU - Southey, Melissa C.
AU - Hopper, John L.
AU - Goldgar, David E.
AU - Singer, Christian F.
AU - Rappaport, Christine
AU - Tea, Muy Kheng M.
AU - Fink-Retter, Anneliese
AU - Hansen, Thomas V.O.
AU - Nielsen, Finn C.
AU - Arason, Aoalgeir
AU - Vijai, Joseph
AU - Shah, Sohela
AU - Sarrel, Kara
AU - Robson, Mark E.
AU - Piedmonte, Marion
AU - Phillips, Kelly
AU - Basil, Jack
AU - Rubinstein, Wendy S.
AU - Boggess, John
AU - Wakeley, Katie
AU - Ewart-Toland, Amanda
AU - Montagna, Marco
AU - Agata, Simona
AU - Imyanitov, Evgeny N.
AU - Isaacs, Claudine
AU - Janavicius, Ramunas
AU - Lazaro, Conxi
AU - Blanco, Ignacio
AU - Feliubadalo, Lidia
AU - Brunet, Joan
AU - Gayther, Simon A.
AU - Pharoah, Paul P.D.
AU - Odunsi, Kunle O.
AU - Karlan, Beth Y.
AU - Walsh, Christine S.
AU - Olah, Edith
AU - Teo, Soo Hwang
AU - Ganz, Patricia A.
AU - Beattie, Mary S.
AU - Van Rensburg, Elizabeth J.
AU - Dorfling, Cecelia M.
AU - Diez, Orland
AU - Kwong, Ava
AU - Schmutzler, Rita K.
AU - Wappenschmidt, Barbara
AU - Engel, Christoph
AU - Meindl, Alfons
AU - Ditsch, Nina
AU - Arnold, Norbert
AU - Heidemann, Simone
AU - Niederacher, Dieter
AU - Preisler-Adams, Sabine
AU - Gadzicki, Dorothea
AU - Varon-Mateeva, Raymonda
AU - Deissler, Helmut
AU - Gehrig, Andrea
AU - Sutter, Christian
AU - Kast, Karin
AU - Fiebig, Britta
AU - Heinritz, Wolfram
AU - Caldes, Trinidad
AU - De La Hoya, Miguel
AU - Muranen, Taru A.
AU - Nevanlinna, Heli
AU - Tischkowitz, Marc D.
AU - Spurdle, Amanda B.
AU - Neuhausen, Susan L.
AU - Ding, Yuan Chun
AU - Lindor, Noralane M.
AU - Fredericksen, Zachary
AU - Pankratz, V. Shane
AU - Peterlongo, Paolo
AU - Manoukian, Siranoush
AU - Peissel, Bernard
AU - Zaffaroni, Daniela
AU - Barile, Monica
AU - Bernard, Loris
AU - Viel, Alessandra
AU - Giannini, Giuseppe
AU - Varesco, Liliana
AU - Radice, Paolo
AU - Greene, Mark H.
AU - Mai, Phuong L.
AU - Easton, Douglas F.
AU - Chenevix-Trench, Georgia
AU - Offit, Kenneth
AU - Simard, Jacques
PY - 2012/1/1
Y1 - 2012/1/1
N2 - Background: Genome-wide association studies (GWAS) identified variants at 19p13.1 and ZNF365 (10q21.2) as risk factors for breast cancer among BRCA1 and BRCA2 mutation carriers, respectively. We explored associations with ovarian cancer and with breast cancer by tumor histopathology for these variants in mutation carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Methods: Genotyping data for 12,599 BRCA1 and 7,132 BRCA2 mutation carriers from 40 studies were combined. Results: We confirmed associations between rs8170 at 19p13.1 and breast cancer risk for BRCA1 mutation carriers [HR, 1.17; 95% confidence interval (CI), 1.07-1.27; P = 7.42 × 10 -4] and between rs16917302 at ZNF365 (HR, 0.84; 95% CI, 0.73-0.97; P = 0.017) but not rs311499 at 20q13.3 (HR, 1.11; 95% CI, 0.94-1.31; P = 0.22) and breast cancer risk for BRCA2 mutation carriers. Analyses based on tumor histopathology showed that 19p13 variants were predominantly associated with estrogen receptor (ER)-negative breast cancer for both BRCA1 and BRCA2 mutation carriers, whereas rs16917302 at ZNF365 was mainly associated with ER-positive breast cancer for both BRCA1 and BRCA2 mutation carriers.Wealso found for the first time that rs67397200 at 19p13.1 was associated with an increased risk of ovarian cancer for BRCA1 (HR, 1.16; 95% CI, 1.05-1.29; P = 3.8 × 10 -4) and BRCA2 mutation carriers (HR, 1.30; 95% CI, 1.10-1.52; P = 1.8 × 10-3). Conclusions: 19p13.1 and ZNF365 are susceptibility loci for ovarian cancer and ER subtypes of breast cancer among BRCA1 and BRCA2 mutation carriers. Impact: These findings can lead to an improved understanding of tumor development and may prove useful for breast and ovarian cancer risk prediction for BRCA1 and BRCA2 mutation carriers.
AB - Background: Genome-wide association studies (GWAS) identified variants at 19p13.1 and ZNF365 (10q21.2) as risk factors for breast cancer among BRCA1 and BRCA2 mutation carriers, respectively. We explored associations with ovarian cancer and with breast cancer by tumor histopathology for these variants in mutation carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Methods: Genotyping data for 12,599 BRCA1 and 7,132 BRCA2 mutation carriers from 40 studies were combined. Results: We confirmed associations between rs8170 at 19p13.1 and breast cancer risk for BRCA1 mutation carriers [HR, 1.17; 95% confidence interval (CI), 1.07-1.27; P = 7.42 × 10 -4] and between rs16917302 at ZNF365 (HR, 0.84; 95% CI, 0.73-0.97; P = 0.017) but not rs311499 at 20q13.3 (HR, 1.11; 95% CI, 0.94-1.31; P = 0.22) and breast cancer risk for BRCA2 mutation carriers. Analyses based on tumor histopathology showed that 19p13 variants were predominantly associated with estrogen receptor (ER)-negative breast cancer for both BRCA1 and BRCA2 mutation carriers, whereas rs16917302 at ZNF365 was mainly associated with ER-positive breast cancer for both BRCA1 and BRCA2 mutation carriers.Wealso found for the first time that rs67397200 at 19p13.1 was associated with an increased risk of ovarian cancer for BRCA1 (HR, 1.16; 95% CI, 1.05-1.29; P = 3.8 × 10 -4) and BRCA2 mutation carriers (HR, 1.30; 95% CI, 1.10-1.52; P = 1.8 × 10-3). Conclusions: 19p13.1 and ZNF365 are susceptibility loci for ovarian cancer and ER subtypes of breast cancer among BRCA1 and BRCA2 mutation carriers. Impact: These findings can lead to an improved understanding of tumor development and may prove useful for breast and ovarian cancer risk prediction for BRCA1 and BRCA2 mutation carriers.
UR - http://www.scopus.com/inward/record.url?scp=84859377440&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-11-0888
DO - 10.1158/1055-9965.EPI-11-0888
M3 - Article
C2 - 22351618
AN - SCOPUS:84859377440
SN - 1055-9965
VL - 21
SP - 645
EP - 657
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 4
ER -